The USFDA has issued Indoco Remedies a warning letter for its Goa manufacturing facilities: unit 2 and 3. The warning letter was served to the company, following the USFDA inspection carried out during August 31September 4, 2016, for which Indoco had been issued six observations. These two units are located in the same complex and have been issued the same warning letter. Both facilities have been inspected five times by the USFDA since 2005. The USFDA has accepted five responses from the company but remains critical regarding the sixth response, which pertains to the leakage issue in a few products, especially for ophthalmic...